JBIO: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, JBIO has $319,433K in assets. $22,971K in debts. $55,085K in cash and cash equivalents.

Balance Sheets	2026-03-31	2025-09-30	2025-06-30
Cash and cash equivalents	55,085	50,106	220,942
Investments	256,210	148,799	-
Prepaid expenses and other current assets	7,222	2,455	2,042
Total current assets	318,517	201,360	222,984
Property and equipment, net	157	176	147
Operating lease right-of-use asset	690	740	777
Other assets	69	174	60
Total assets	319,433	202,450	223,968

Accounts payable	3,979	1,350	7,586
Accrued expenses and other current liabilities	14,852	14,012	8,091
Related party accrued expenses and other current liabilities	794	2,048	2,380
Warrant liability, related party	2,667	4,947	3,563
Total current liabilities	22,292	22,357	21,620
Convertible notes payable	-	0	-
Long-term lease liability	679	747	792
Total liabilities	22,971	23,104	22,412
Series a non-voting convertible preferred stock, 0.0001 par value 12,622 shares authorized as of both march 31, 2026 and december 31, 2025, 12,622 shares issued and outstanding as of both march 31, 2026 and december 31, 2025	2	2	-
Common stock, 0.0001 par value 300,000,000 shares authorized as of march 31, 2026 and december 31, 2025, respectively 49,345,967 and 49,316,287 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively	5	3	3
Additional paid-in capital	511,554	321,769	318,857
Accumulated other comprehensive (loss) income	-342	29	-24
Accumulated deficit	-214,757	-142,457	-117,282
Total stockholders' equity	296,462	179,346	201,556
Total liabilities and stockholders' equity	319,433	202,450	223,968

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.